Levothyroid

Quick links to important sections

Levothyroid

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Levothyroid

Property Description
Active ingredient Levothyroxine sodium (L-thyroxine)
Form Oral tablet
Pharmacological class Thyroid hormone replacement, Endocrine agent
Common use Hormone substitution to correct a deficiency
Origin Synthetic

Levothyroid is a prescription-only pharmaceutical product classified as a thyroid hormone replacement and an endocrine agent. It is defined by its active ingredient, Levothyroxine sodium (L-thyroxine), and its purpose is to serve as a hormone substitute to correct a specific biological deficiency, a practice clinically recognized for ensuring metabolic consistency.


Levothyroid: Definition and Active Composition

Levothyroid contains the single active ingredient Levothyroxine sodium, which is a synthetic compound structurally and chemically identical to the essential hormone thyroxine (T4) naturally produced by the human thyroid gland. This synthetic origin ensures a standardized, high-purity product. The preparation is a product whose chemical structure matches the native hormone, ensuring biological equivalence when administered. The active ingredient is combined with necessary solid excipients to form an oral tablet.


What Type of Medicine is Levothyroid?

Levothyroid belongs to the pharmacological class of thyroid hormone replacements, functioning as an essential endocrine agent that substitutes the missing natural hormone. The medication is provided in the dosage form of an oral tablet, making it a systemic medication intended for oral administration. Its composition as a single-ingredient product featuring only L-thyroxine distinguishes it from combined natural extracts, offering a consistent and standardized method of replacement therapy recognized for its fundamental role in endocrine health.


General Purpose: Restoring Metabolic Balance

The general purpose of Levothyroid is to achieve thyroid function normalization by providing the body with the necessary T4 to regulate its core energy processes. The physiological action is hormone replacement, which is utilized because T4 is the primary regulatory hormone governing the body's metabolism, including energy expenditure and cellular function. By supplying this missing hormone, the medication helps restore the systemic metabolic balance necessary for supporting overall physiological health.

Regulatory References

  1. Levothyroxine - WHO Essential Medicines List

What side effects are possible with Levothyroid?

Possible Side Effects and Safety Information

The safety profile for Levothyroid (Levothyroxine sodium) is defined by official regulatory bodies, who classify most adverse reactions as symptoms of therapeutic overdosage (hyperthyroidism), meaning they are related to receiving a dose higher than the body requires. These effects are generally reversible upon dose adjustment, but their presence signifies that the dose may be too high.


Key Adverse Reactions and Systemic Effects

Adverse effects documented in regulatory labeling primarily reflect increased metabolic activity. These effects span several System-Organ Classes, including:

  • Central Nervous System: Headache, nervousness, hyperactivity, and tremors.
  • Cardiovascular System: Palpitations, increased pulse rate, and tachycardia.
  • Metabolism: Weight loss, heat intolerance, and excessive sweating.
  • Gastrointestinal: Diarrhea and abdominal cramping.

Serious adverse reactions are predominantly cardiac events linked to over-replacement, such as serious arrhythmias, angina pectorus, and, rarely, myocardial infarction or cardiac arrest. Seizures have also been reported rarely.


Population and Duration Safety Notes

Official prescribing information highlights specific safety considerations for certain patient groups and duration of use:

  • Elderly Patients: Have an elevated risk of developing serious cardiac adverse reactions (e.g., atrial fibrillation) if over-replaced.
  • Post-menopausal Women: Long-term over-replacement therapy is associated with a risk of decreased bone mineral density.
  • Pediatric Patients: Transient hair loss may occur during the first few months of therapy.

Levothyroid is formally contraindicated in conditions such as untreated thyrotoxicosis, uncorrected adrenal insufficiency, and recent acute myocardial infarction. It also carries an official regulatory constraint stating it should not be used for the treatment of obesity or for weight loss.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage of Levothyroid (Levothyroxine sodium) results in clinical manifestations consistent with hyperthyroidism, due to excessive thyroid hormone activity. The documented manifestations are primarily signs of a hypermetabolic state.

Documented Overdose Manifestations

System Clinical Signs (Official Labeling)
Cardiovascular Palpitations, tachycardia, increased blood pressure, angina pectoris, arrhythmias.
CNS/General Nervousness, hyperactivity, tremors, insomnia, heat intolerance, excessive sweating, weight loss.

Required Emergency Actions

Overdosage may produce serious or even life-threatening manifestations of toxicity, including the risk of myocardial infarction (heart attack), cardiac arrest, and thyrotoxic crisis. Patients must seek immediate medical attention for severe symptoms such as chest pain, rapid pulse, or persistent fever. The treatment approach is symptomatic and supportive, and the product label states that the dosage must be reduced or therapy temporarily discontinued upon the appearance of overdosage signs. No specific antidote is officially known or documented.

Population-Specific Risks

The elderly and patients with pre-existing cardiovascular disease have a significantly increased risk of severe cardiac events from overtreatment. In pediatric patients, overdosage can accelerate bone age, potentially compromising adult stature.

Therapeutic Uses of Levothyroid

What Levothyroid Treats: Main Uses and Benefits

Levothyroid is relevant for managing conditions presenting with systemic or localized discomfort. It is commonly used across conditions presenting with acute episodes, such as Hashimoto's disease and following a thyroidectomy (surgical removal of the thyroid gland).

Easing Fatigue and Supporting Mental Comfort

The medication is applied when appropriate to help with symptoms related to physical discomfort and low energy, specifically chronic fatigue, physical sluggishness, and difficulty with mental focus. It offers symptomatic relief that helps patients cope more steadily with difficult manifestations and contributes to improved day-to-day comfort during symptomatic periods.


Supporting Metabolism and Physical Well-being

The medication is commonly used for managing the physical effects linked to symptoms that create noticeable physiological strain, which include unexplained weight changes, increased cold sensitivity, dry skin, hair thinning, and symptoms related to functional stress, such as constipation. It is commonly used to help with improving day-to-day comfort and assists with maintaining functional stability related to metabolic processes.

Quick Fact: May assist with Cold Intolerance The medication assists with managing the body's increased sensitivity to cold, which is a symptom related to systemic imbalance.

Regulatory References

  1. NIH MedlinePlus overview of Levothyroxine

Eligibility and Restrictions for Use

Who Can and Cannot Use Levothyroid?

The eligibility for Levothyroid is strictly governed by governmental regulatory classifications based on patient health status and age.

Eligibility Scope Category Official Regulatory Statement
Populations for whom use is allowed Adults, children, and geriatric patients for hypothyroidism replacement therapy.
Populations for whom use is contraindicated Patients with Overt Thyrotoxicosis; Acute Myocardial Infarction; Uncorrected Adrenal Insufficiency.

Age-Related Eligibility Rules: Use is established and approved across all pediatric age groups. However, geriatric patients must be initiated on lower starting doses due to the increased risk of cardiac complications.

Condition-Specific Eligibility Rules: Patients with Underlying Cardiovascular Disease require caution and lower initial doses. Use in Concomitant Adrenal Insufficiency is conditionally restricted: replacement glucocorticoid therapy must be administered prior to initiation of Levothyroid. Pregnancy and lactation are generally permitted and necessary for maternal health, with dose requirements often increasing during pregnancy.

Eligibility-Related Restrictions: The medicine is explicitly contraindicated for the treatment of obesity or for weight loss in individuals with normal thyroid function. Long-term use in postmenopausal women may be associated with decreased bone mineral density if over-replacement occurs.

Connection to the overall eligibility profile: Regulatory documents define Levothyroid's eligibility primarily by establishing strict absolute contraindications related to acute cardiac and endocrine statuses, alongside an explicit prohibition of use for weight loss. For otherwise eligible populations, the profile specifies conditional use requirements for geriatric or cardiovascular risk groups.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Levothyroid's interaction profile, as documented in official regulatory sources, is defined by three primary mechanisms: reduced absorption, increased metabolic clearance, and pharmacodynamic potentiation.

Interaction-Related Restrictions and Constraints

  • Absorption-Reducing Agents: Co-administration with substances that bind Levothyroid in the gastrointestinal tract, such as Iron supplements (Ferrous Sulfate), Calcium salts (Calcium Carbonate), Antacids, and Bile Acid Sequestrants, necessitates a mandatory time separation of several hours. This procedural constraint ensures consistent absorption and maintains adequate plasma exposure.

  • Altered Clearance: Medicines that accelerate Levothyroid's degradation, including Rifampin and Phenytoin, are documented to increase its metabolic clearance. Co-administration requires monitoring to assess the resulting reduction in plasma concentration.

  • Pharmacodynamic Potentiation: Levothyroid may enhance the effect of Oral Anticoagulants (e.g., Warfarin), increasing the risk of bleeding. It may also increase the dosage requirements for Antidiabetic Agents (e.g., Insulin), a pharmacodynamic effect noted in regulatory labels. Furthermore, the official labeling notes that the interaction risk with certain agents is heightened in elderly patients and those with existing cardiovascular conditions.

Mechanism of Action

Nuclear Receptor-Mediated Gene Regulation

Levothyroxine (synthetic T4), a prohormone, is transported into target cell nuclei where its deiodination yields the active hormone, Triiodothyronine (T3). This active T3 binds to thyroid hormone receptors (TRs), altering the conformation of the receptor complex and resulting in the transcriptional modulation of specific DNA sequences.


Systemic Metabolic and Physiological Modulation

The resultant altered protein expression impacts cellular processes governed by specific signaling mediators, influencing downstream systemic physiological metrics. This modifies early molecular steps to increase the basal metabolic rate and modulate pathway activity affecting diverse cellular processes, including cardiac output, and intermediary metabolism (lipids and carbohydrates).


Hypothalamic-Pituitary-Thyroid (HPT) Axis Feedback

The elevation in circulating thyroid hormones (T4 and T3) engages a key negative feedback regulation mechanism within the HPT axis. By binding to TRs in the pituitary gland, the hormones suppress the secretion of Thyrotropin (TSH), leading to a decreased release of TSH.

Dosage and Administration Information

Levothyroid is administered primarily through the oral route for long-term hormone replacement, typically as a once-daily therapy. An intravenous (IV) formulation is reserved solely for acute, inpatient management of myxedema coma.


Dosing Principles and Titration Schedule

The full replacement dose for healthy adults is generally around 1.6 mcg/kg of body weight per day. However, initial dosing must be individualized. Older adults or patients with known cardiac issues initiate therapy with a reduced starting dose, commonly 12.5 mcg or 25 mcg daily. Dosage adjustments are systematic, occurring at intervals of four to eight weeks in small increments, such as 12.5 mcg or 25 mcg. Pediatric patients receive doses based on weight, with infants aged 0–3 months requiring the highest per-kilogram amount.


Administration Conditions

To ensure reliable absorption, the oral dose must be taken on an empty stomach, generally 30 to 60 minutes before breakfast. A crucial condition for proper use is maintaining a separation of at least four hours between the dose and consuming products containing calcium, iron, or antacids, as these substances can significantly inhibit uptake. For infants who cannot swallow tablets, the medication may be crushed and suspended in a small amount of water for immediate administration; this liquid preparation must not be stored. The treatment is structured as a lifelong protocol to sustain necessary metabolic balance.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Levothyroid

Levothyroid is a pharmaceutical product evaluated in research for thyroid hormone replacement, and its use was evaluated over several decades. This overview focuses strictly on the types of studies that exist, what they measured, and what remains uncertain.


Evidence for Use in Overt Primary Hypothyroidism

Research for established thyroid deficiency relies on long-term observational cohort studies and systematic reviews. Studies monitored the primary endpoint of achieving biomarker normalization (restoring TSH and thyroid hormone levels to target ranges). Researchers also examined how outcomes related to physical discomfort (e.g., chronic fatigue and cold sensitivity) evolved in the observed populations. Existing evidence provides limited insight into why a subset of patients reports persistent symptoms even when their TSH levels appear normal.


Evidence for Use in Subclinical Hypothyroidism (SCH)

Research into SCH was evaluated in numerous Randomized Controlled Trials (RCTs), many of which explored comparing Levothyroid to placebo. These trials examined outcomes related to cardiovascular events and patient-reported outcomes (e.g., quality of life). Findings related to symptomatic improvement in older, non-pregnant adults were mixed, and certainty remains low for clinical benefits in this group. For pregnant women with SCH, research was observed in some studies to provide insight into outcomes related to adverse pregnancy events.


Evidence for TSH Suppression After Thyroid Cancer Treatment

Levothyroxine was evaluated as an adjunct to maintain a lower than normal TSH level following surgery for certain thyroid cancers. Long-term observational studies monitored endpoints related to survival and recurrence frequency. Studies monitored the consistent achievement of specific target TSH suppression levels as a key study endpoint. Mixed findings exist regarding the precise level of TSH suppression required, and research is ongoing regarding the careful balance with managing potential adverse effects.


Long-Term Studies and Durability of Response

Research was studied for long-term durability of the effects in chronic conditions. Follow-up and observational studies were observed in settings evaluating daily-life functioning. However, long-term effects are not fully established regarding continued quality of life, as follow-up durations were limited in many comparative trials.


Evidence in Specific Patient Populations

Evidence was evaluated in studies focusing on older adults (typically aged ge 65 years), where findings were mixed regarding symptomatic improvement.

Evidence in Children and Adolescents

Research was studied for use in pediatric populations. Studies explored the patterns of replacement monitored to support growth and developmental outcomes.


Unanswered Questions and Research Gaps

The current evidence describes several areas where research is ongoing. These include: why some patients with TSH levels in the normal range continue to report perceived discomfort, and where comparative evidence is limited for Levothyroxine monotherapy against combination T4/T3 therapy.

Key Studies & References Levothyroxine - StatPearls (General Indications, Metabolism, and Pediatric Use)

Frequently Asked Questions (FAQ)

Common questions about Levothyroid (FAQ)


Q: What is the main difference between Levothyroid and Synthroid?

Levothyroid and Synthroid are both brand names for the exact same active ingredient: levothyroxine sodium (synthetic T4). Official regulatory documents state that both contain the same active ingredient and are used as replacement therapy for hypothyroidism. Differences typically relate to the inactive ingredients used in the tablets.


Q: Can certain foods or drinks interfere with how Levothyroid is absorbed?

Yes, official labeling notes that substances such as soybean flour, cottonseed meal, walnuts, and high amounts of dietary fiber can reduce the absorption of levothyroxine. For consistent absorption, it is recommended that the medication be administered on a consistent empty stomach, separated from these food items.


Q: What are the signs that my Levothyroid dosage might be too high?

Adverse reactions listed in official documents are primarily symptoms of receiving too high a dose (therapeutic overdosage, or hyperthyroidism). Signs include symptoms like headaches, nervousness, insomnia, excessive sweating, and an increased or irregular pulse rate (arrhythmias). These effects usually resolve if the dosage is reduced.


Q: Can Levothyroid cause hair thinning or loss?

Yes, regulatory information indicates that some people may experience transient, temporary partial hair loss during the first few months after starting treatment. This is more commonly reported in pediatric patients. The effect is often reported to be temporary as the body adjusts to the therapy.


Q: Does Levothyroid interact with common vitamins or supplements?

Yes. Supplements containing calcium salts or iron (ferrous sulfate) can significantly decrease the absorption of levothyroxine. Official guidance states a separation of at least four hours is necessary between taking the medicine and taking these supplements. Additionally, official warnings advise that biotin supplements can interfere with lab tests, potentially leading to inaccurate TSH/T4 level results.


Q: Why are people with heart conditions cautious about starting Levothyroid?

Official warnings state that overtreatment (a dose that is too high) can increase heart rate and may precipitate serious cardiac issues like angina or arrhythmias in susceptible individuals. Regulatory guidance indicates that patients with existing heart conditions often initiate therapy with a lower dose, and careful monitoring is necessary.


Q: What is the connection between Levothyroid and osteoporosis risk?

Official warnings note that long-term use at doses higher than necessary (over-replacement) can increase bone loss, leading to decreased bone mineral density. This risk is particularly noted in post-menopausal women. Regulatory documents emphasize that using the minimum effective dose necessary is important to manage this risk.


Q: How quickly should I start feeling better after taking Levothyroid?

According to official information, the full peak therapeutic effect of Levothyroid may not be achieved for about four to six weeks after starting treatment or changing a dose. TSH levels are typically monitored after this period to assess the adequacy of the dose.


Q: Is it normal to feel more energetic after starting Levothyroid?

Since the medicine replaces a missing hormone that regulates metabolism and energy, a return to normal energy levels is an intended outcome of treatment. However, official safety information lists excessive nervousness or hyperactivity as adverse reactions that can occur if the dosage is too high.


Q: What are the most common minor side effects of Levothyroid?

The most frequently noted adverse effects, which are usually signs of overdosage (receiving too much medicine), include headache, nervousness, irritability, tremors, and palpitations (feeling the heart beat quickly).


Q: Can Levothyroid cause changes in sleep patterns?

Yes. Official safety data lists insomnia (trouble sleeping) as a potential adverse reaction. This symptom is typically associated with receiving a dose higher than the body requires, as it speeds up metabolic activity.


Q: Are there any long-term effects of taking Levothyroid for many years?

Long-term use at a dose that is too high (over-replacement) carries documented risks. These risks include decreased bone mineral density and an increased likelihood of cardiac events, such as an irregular heartbeat, especially in older adults. To manage these long-term risks, maintaining the minimum effective dose necessary is emphasized in official guidance.


Q: Can Levothyroid affect my weight, either loss or gain?

Levothyroid is specifically not approved for the treatment of obesity or for weight loss in people who have normal thyroid function. Weight loss is listed as a symptom of overdosage. Weight gain is a common symptom of untreated hypothyroidism, and correcting the deficiency may help manage this.


Q: Are there generic versions of Levothyroid available?

Yes. Levothyroid is a brand name for levothyroxine sodium. The FDA has approved several generic and other brand-name formulations of levothyroxine sodium tablets and capsules.


Q: What are the typical benefits of long-term Levothyroid treatment?

Official information states that the medicine provides replacement therapy to correct a thyroid hormone deficiency. This helps restore proper metabolic balance and is used to manage and potentially mitigate long-term negative impacts on critical functions like cardiovascular health, cognitive function, and lipid/glucose metabolism.


Q: Does Levothyroid help with symptoms like brain fog?

Levothyroid therapy is intended to correct the deficiency that can cause negative effects on cognitive function. The medication is expected to reverse the symptoms of hypothyroidism, which often includes issues like fatigue and difficulty concentrating (sometimes described as brain fog).


Q: How long does it take for Levothyroid to reach full effect in the body?

The time required to reach the peak therapeutic effect is documented to be about four to six weeks. This is a key factor in how dosage adjustments are timed.


Q: Can switching between generic and brand-name Levothyroid cause problems?

Regulatory bodies classify levothyroxine sodium as a drug with a narrow therapeutic index (NTI). This means small differences in absorption can have significant clinical effects. Therefore, any change in product, whether from brand to generic or one brand to another, often requires careful re-monitoring of TSH levels.


Q: Does being lactose intolerant affect taking Levothyroid?

Some formulations of levothyroxine tablets contain lactose as an inactive ingredient. Patients with known lactose intolerance should review the ingredients list for their specific prescribed formulation.


Q: What research supports the use of Levothyroid for hypothyroidism?

Levothyroid is an FDA-approved medicine indicated as a hormone replacement therapy for hypothyroidism. This indication is supported by decades of clinical experience and studies that demonstrate its ability to consistently restore necessary thyroid hormone levels and correct clinical signs of the deficiency.


Q: Can Levothyroid impact my cholesterol levels?

Yes. A function of thyroid hormone is to regulate lipid metabolism (cholesterol). Levothyroid is intended to correct the deficiency and is expected to help normalize cholesterol levels that may have been elevated due to the underactive thyroid.


Q: What storage conditions are best for Levothyroid tablets?

Official instructions state that tablets must be stored at controlled room temperature, generally between 20 C and 25 C (68 F and 77 F). To maintain the potency of the medicine, it must be protected from heat, moisture, and light.


Q: Why is my doctor checking my levels so frequently when I first start Levothyroid?

The adequacy of therapy is determined by periodic monitoring of TSH and/or T4 levels. Regulatory guidelines recommend systematic dose adjustments at intervals of four to eight weeks until the required TSH target range is successfully achieved.


Q: Do over-the-counter pain relievers interact with Levothyroid?

While regulatory labels do not specifically list all common over-the-counter pain relievers, they do note that many drugs can alter the metabolism of levothyroxine. If any new medication is started, TSH levels may need to be monitored more closely to ensure the levothyroxine dose remains correct.


Q: Is it normal to experience temporary side effects when first starting the medication?

Yes. A commonly noted temporary side effect is transient hair loss that can occur in the first few months. Other adverse effects are primarily related to receiving too high a dose and should generally resolve once the dose is properly adjusted.


Q: Can Levothyroid be taken with coffee?

Studies noted in drug information suggest that coffee may decrease the absorption of levothyroxine. Official product information suggests separating the administration of the tablet from consuming coffee by at least one hour to ensure consistent and reliable absorption.


Q: What are some less common but possible side effects of this medicine?

The most serious, though less common, adverse effects are linked to over-replacement (too high a dose). These include serious cardiac events, such as arrhythmias (irregular heart rhythm) or angina, and, rarely, seizures.


Q: What is the role of Levothyroid in treating an enlarged thyroid (goiter)?

Levothyroid is indicated to help decrease the size of an enlarged thyroid gland, known as a goiter. By providing the body with T4 hormone, it helps suppress the secretion of TSH, which is often a stimulus for goiter growth.

How should Levothyroid be stored and disposed of?

How to Store and Dispose of Levothyroxine Sodium

Storage Requirements

Levothyroxine sodium must be stored under specific conditions to maintain its potency.

  • Temperature: Store the tablets at controlled room temperature, generally defined as between 20 C and 25 C (68 F and 77 F).
  • Environmental Protection: The medicine must be protected from degradation by heat, moisture, and light. It is required to keep the product in its original container to maintain these protections.
  • Safety: Always store the medication out of the reach of children.

Stability and Disposal Instructions

Certain preparations have limited stability and must be handled promptly.

  • Stability: If a tablet is crushed and mixed with water for immediate use, the resulting suspension must not be stored.
  • Disposal: Unused or expired levothyroxine sodium must be disposed of in accordance with local requirements for medicinal products. Discarding any unused portion of a reconstituted injectable solution is also mandatory.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Levothyroid found in:

A-Z Index: